Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis
about
Insulin-dependent diabetes mellitus: a model for the study of multifactorial disordersGenetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitusHLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility geneUnusual clustering of diseases in a Canadian Old Colony (Chortitza) Mennonite kindred and community.Major histocompatibility complex-linked diabetogenic gene of the nonobese diabetic mouse. Analysis of genomic DNA amplified by the polymerase chain reaction.HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ allelesThe first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis.Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies.RFLP analysis of HLA-DR beta and -DQ beta genes in the Korean patients with insulin-dependent diabetes mellitusPolymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouseI-E+ nonobese diabetic mice develop insulitis and diabetes.The genetics of type I (insulin dependent) diabetes mellitus.An extended HLA-D region haplotype associated with celiac disease.Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.Insulin dependent diabetes mellitus hypothesis of autoimmunity.Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic miceThe major histocompatibility complex and insulin dependent (type 1) diabetes.HLA and insulin-dependent diabetes: an overview.Polymorphism of HLA class II genes in various diseases.HLA heterozygosity in insulin-dependent diabetes is most frequent at the DQ locus.Characterization of PPD-specific T-cell lines generated in type I (insulin-dependent) diabetic and healthy individuals.HLA antigen frequencies and Wegener's granulomatosis.Genes predisposing to IDDM in multiplex families.PCR-SSO typing in HLA-disease association studies.HLA antigens in Asian Indian patients with Graves' disease.HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.A peptide-binding assay for the disease-associated HLA-DQ8 molecule.
P2860
Q28764592-8C833FFD-1703-41CB-917A-023C8490819CQ28764595-904CD58A-5BE6-457B-8343-1ED06EEE5285Q30891390-D69FBF50-4CA5-4538-A4FC-097EA5D361C1Q33562420-737DEBC6-9E3B-4158-AE6C-7A616927CAEEQ33640310-B18F909C-C6FD-47C9-B6B9-8E37FDC4D0D3Q33712058-E071D6B9-9AA6-43B1-89AD-49947954189EQ33835834-8912C431-8080-401B-8F7A-6410D478FE1CQ34101592-74201ECF-F6FA-4920-8256-E1CFCA533C0DQ34239134-5E202CCF-45C5-4781-A515-A022D65F0975Q34326526-64F190D8-A090-417D-8D8D-9054B2A25166Q34346951-CE40068C-F2C3-4F31-AB0E-C88E4E94BC04Q34568059-5DBB4DB3-9FD6-4B2E-B051-64D7BC20EC92Q34614636-F545F197-16F8-496D-B40A-61B550813933Q35194617-0B4DF6EE-5B77-42B9-A408-7DE6A5932A37Q35604859-8E1C6C12-063A-4431-8655-662EA1F486BBQ35612872-305AF893-C8DD-46FE-857B-8589157C001FQ35643153-C7A3527C-BE4F-41DE-B73E-467088A1CA9AQ35948496-16A9C988-1661-4254-8345-D3955A94DF7CQ36350204-523AB2FD-5446-436E-B12D-80C84B9E1D27Q36352723-6EB734F2-7434-40D6-A55F-80852BF557FBQ36362338-634DD6C5-0E20-4F6C-8C44-899E30F93F2AQ36365038-102409ED-6401-4C15-9067-C5B93C0D1BC8Q36415809-9FCB3F81-3E84-4136-A9D0-F7F8506D68B1Q36635307-A45F6C3E-F365-4AD2-9748-824A1D3EAE90Q36681942-5E02DD53-29F0-462A-9A99-08A4D9FA6432Q37384851-DE906AC2-26C3-4333-A4A7-0F85314AD66AQ37424652-508C85A4-93D7-4F0F-8A35-C8E44F9A3711Q37606840-A08F1FB2-4CCD-4624-872C-11D0E02E9357Q37726181-4D141ED6-A778-4CB1-9D9C-5191EB689608Q38379652-169178FB-23B3-4EF4-A7CD-70E8435E7BF0Q38643203-BCA6C212-23CF-4EDB-BABE-A7CCB2D9A59CQ39610048-EAA39157-B627-466C-80FE-EDC5D2BEC1D3Q41229004-5B9B9600-9632-49F7-A312-67CE2F5F178DQ41281596-5BFEC96D-557F-4375-8D67-2B5CC01C527CQ41839075-EFE944A4-FCC7-4342-9DDC-8F23ADF42F99Q42640281-8FA6E4F9-20E5-4017-B65B-8478932042F4Q43693984-03AE3258-7789-4112-A711-13F93DB540CFQ43753149-607BD148-3C97-4FB2-8279-9088A0ECAB66Q45009267-BD2A37DD-B6C8-4E3E-9EC3-FD97620FF94EQ47886260-F478A5B8-9DFD-4C15-93C5-8C717F70D277
P2860
Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@ast
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@en
type
label
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@ast
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@en
prefLabel
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@ast
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@en
P2093
P2860
P356
P1476
Specific genomic markers for t ...... juvenile rheumatoid arthritis
@en
P2093
P2860
P304
P356
10.1084/JEM.164.1.345
P407
P577
1986-07-01T00:00:00Z